JHSGX
Price
$32.23
Change
-$0.75 (-2.27%)
Updated
Nov 13 closing price
Net Assets
3.11B
RGEBX
Price
$83.30
Change
-$1.87 (-2.20%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

JHSGX vs RGEBX

Header iconJHSGX vs RGEBX Comparison
Open Charts JHSGX vs RGEBXBanner chart's image
JHancock U.S. Growth R4
Price$32.23
Change-$0.75 (-2.27%)
VolumeN/A
Net Assets3.11B
American Funds Growth Fund of Amer R2E
Price$83.30
Change-$1.87 (-2.20%)
VolumeN/A
Net Assets340.4B
JHSGX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
JHSGX vs. RGEBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHSGX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 340B vs. JHSGX (3.11B). JHSGX (0.00) and RGEBX (0.00) have matching dividends . JHSGX was incepted earlier than RGEBX: JHSGX (11 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than JHSGX (0.96). JHSGX is a more actively managed with annual turnover of: 80.00 vs. RGEBX (25.00). JHSGX has a lower initial minimum investment than RGEBX: JHSGX (0) vs RGEBX (250). JHSGX annual gain was more profitable for investors over the last year : 10.56 vs. RGEBX (8.10). JHSGX return over 5 years is better than : 41.45 vs. RGEBX (36.65).
JHSGXRGEBXJHSGX / RGEBX
Total Expense Ratio0.851.0978%
Annual Report Gross Expense Ratio0.961.0988%
Fund Existence11 years11 years-
Gain YTD20.89419.219109%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.11B340B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.568.10130%
Returns for 3 years65.7362.39105%
Returns for 5 years41.4536.65113%
Returns for 10 years104.3493.78111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG60.150.91
+1.54%
Bright Minds Biosciences
SRPT18.000.02
+0.11%
Sarepta Therapeutics
WSBCP24.98N/A
N/A
WesBanco
XP19.21-0.59
-2.98%
XP
HKIT2.37-0.39
-14.13%
Hitek Global